RPS6KB1 and pituitary tumor: Consistent with the immunoblot results, BT significantly suppressed the expression of phosphorylated S6K1 (Figure 4(c)), suggesting that mTORC1 inhibition may contribute to BT-induced cell death in pituitary tumors.